stoxline Quote Chart Rank Option Currency Glossary
  
AtriCure, Inc. (ATRC)
20.97  -1.09 (-4.94%)    06-13 16:00
Open: 21.89
High: 22.06
Volume: 531,795
  
Pre. Close: 22.06
Low: 20.86
Market Cap: 1,015(M)
Technical analysis
2024-06-13 4:41:42 PM
Short term     
Mid term     
Targets 6-month :  26.44 1-year :  28.05
Resists First :  22.63 Second :  24.02
Pivot price 22.24
Supports First :  20.39 Second :  16.97
MAs MA(5) :  21.84 MA(20) :  22.34
MA(100) :  27.98 MA(250) :  36.72
MACD MACD :  -0.5 Signal :  -0.5
%K %D K(14,3) :  22.6 D(3) :  27.2
RSI RSI(14): 37.6
52-week High :  59.61 Low :  20.19
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ATRC ] has closed below the lower bollinger band by 13.5%. Bollinger Bands are 58.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 22.08 - 22.21 22.21 - 22.32
Low: 20.58 - 20.71 20.71 - 20.83
Close: 20.78 - 20.99 20.99 - 21.18
Company Description

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Headline News

Thu, 13 Jun 2024
AtriCure (NASDAQ:ATRC) Trading Down 5% - MarketBeat

Wed, 12 Jun 2024
Seven Eight Capital LP Takes Position in AtriCure, Inc. (NASDAQ:ATRC) - Defense World

Wed, 12 Jun 2024
First Light Asset Management LLC Has $48.16 Million Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

Tue, 11 Jun 2024
Wasatch Advisors LP Has $18.55 Million Stake in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

Mon, 10 Jun 2024
CenterBook Partners LP Cuts Position in AtriCure, Inc. (NASDAQ:ATRC) - Defense World

Thu, 02 May 2024
AtriCure, Inc. (ATRC) Q1 2024 Earnings Call Transcript - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 48 (M)
Shares Float 47 (M)
Held by Insiders 3.2 (%)
Held by Institutions 104.8 (%)
Shares Short 3,090 (K)
Shares Short P.Month 3,200 (K)
Stock Financials
EPS -0.81
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 9.43
Profit Margin -9 %
Operating Margin -10.1 %
Return on Assets (ttm) -3.9 %
Return on Equity (ttm) -8.2 %
Qtrly Rev. Growth 16.3 %
Gross Profit (p.s.) 0
Sales Per Share 8.56
EBITDA (p.s.) -0.42
Qtrly Earnings Growth 0 %
Operating Cash Flow -12 (M)
Levered Free Cash Flow -16 (M)
Stock Valuations
PE Ratio -26.22
PEG Ratio -1.5
Price to Book value 2.22
Price to Sales 2.44
Price to Cash Flow -81.49
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android